Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGrainger plc Regulatory News (GRI)

Share Price Information for Grainger plc (GRI)

Share Price is delayed by 15 minutes
Get Live Data
165.10    -2.70 (-1.61%)
Bid:
165.30
Ask:
165.50
Spread: 0.20 (0.121%)
Market Cap: £1.22b
GRI Live PriceLast checked at - London Stock Exchange

Intraday Grainger plc Share Chart

Rule 8.3- Grainger PLC

28 Jul 2008 13:47

RNS Number : 0236A
BlackRock Group
28 July 2008
Β 

ο»Ώ

FORM 8.3

DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE

(Rule 8.3 of the City Code on Takeovers and Mergers)

Β 

1. KEY INFORMATION

Name of person dealing (Note 1)

BlackRock Group

Company dealt in

Grainger Plc

Class of relevant security to which the dealings being disclosed relateΒ (Note 2)

OrdΒ GBP 0.05

Date of dealing

25thΒ July 2008Β 

2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

Β 

(a)

Interests and short positions (following dealing) in the class of relevant security dealt inΒ (Note 3)

Β 

Β 

Long

Short

Β 

NumberΒ 

(%)

Number

(%)

(1) Relevant securities

3,177,824

2.47%

(2) Derivatives (other than options)

226,736

0.17%

(3) Options and agreements to purchase/sell

Total

3,404,560

2.65%

Β 

(b)

Interests and short positions in relevant securities of the company, other than the class dealt inΒ (Note 3)

Β Class of relevant security:Β 

Long

Short

Β 

Number

(%)

Number

(%)

(1) Relevant securitiesΒ 

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

Β 

(c) Rights to subscribeΒ (Note 3)

Β 

Class of relevant security:

Details

3. DEALINGSΒ (Note 4)

Β 

(a) Purchases and sales

Β 

Purchase/saleΒ 

Number of securities

Price per unit (Note 5)

Β (b) Derivatives transactions (other than options)

Β 

Product name, e.g. CFD

Long/short (Note 6)

Number of securities (Note 7)

Price per unit (Note 5)

CFD

Short

25,000

GBP 2.2667

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Β 

Product nameΒ ,e.g. call optionΒ 

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise priceΒ 

Type, e.g. American, European etc.

Expiry date

Option moneyΒ paid/received per unit (Note 5)Β 

Β 

Β (ii) Exercising

Β 

Product name, e.g. call option

Number of securitiesΒ 

Exercise price per unit (Note 5)

Β 

(d) Other dealings (including new securities)Β (Note 4)

Β 

Nature of transaction (Note 8)Β 

Details

Price per unit (if applicable)Β (Note 5)

4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None……………………………………………………………………

……………………………………………………………………

Is a Supplemental Form 8 attached?Β (Note 9) NO

Β 

Β 

Date of disclosure

28thΒ July 2008

Contact name

Kai Chew

Telephone number

020 7743 2602

If a connected EFM, name of offeree/offeror with which connected

N/A

If a connected EFM, state nature of connection (Note 10)

N/A

Notes

The Notes on Form 8.3 can be viewed on the Takeover Panel's website atΒ www.thetakeoverpanel.org.uk

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
RETFGGZNZRLGRZM
Date   Source Headline
9th Feb 20227:00 amRNSTrading Update
8th Feb 202210:10 amRNSDirector/PDMR Shareholding
4th Feb 202212:26 pmRNSTotal Voting Rights
4th Feb 202212:26 pmRNSDirector/PDMR Shareholding
26th Jan 202211:47 amRNSHolding(s) in Company
11th Jan 20221:13 pmRNSAGM Statement
10th Jan 202211:43 amRNSDirector/PDMR Shareholding
20th Dec 202110:26 amRNSDirector/PDMR Shareholding
20th Dec 202110:20 amRNSDirector/PDMR Shareholding
6th Dec 202111:31 amRNSDirector/PDMR Shareholding
24th Nov 202110:03 amRNSEBT purchase
23rd Nov 20217:00 amRNSGrainger Trust Board Changes
22nd Nov 20217:00 amRNSDirector of Investment Appointments
19th Nov 20217:00 amRNSAppointment of Chief People Officer
18th Nov 20217:00 amRNSFull Year Financial Results
17th Nov 20217:00 amRNSAcquisition of two sites for direct development
8th Nov 20219:59 amRNSTotal Voting Rights
8th Nov 20219:58 amRNSDirector/PDMR Shareholding
14th Oct 20217:00 amRNSPost-Close FY21 Trading Update
14th Oct 20217:00 amRNSAcquisition
12th Oct 20218:48 amRNSDirector/PDMR Shareholding
5th Oct 20214:14 pmRNSDirector/PDMR Shareholding
5th Oct 20214:13 pmRNSBlock listing Interim Review
1st Oct 202111:45 amRNSTotal Voting Rights
30th Sep 20213:06 pmRNSDirector/PDMR Shareholding
9th Sep 20211:40 pmRNSTotal Voting Rights
8th Sep 20212:05 pmRNSHolding(s) in Company
8th Sep 20219:25 amRNSDirectorate Change
7th Sep 202110:24 amRNSDirector/PDMR Shareholding
2nd Sep 20215:30 pmRNSGrainger
2nd Sep 20217:00 amRNSResults of Placing
1st Sep 20214:35 pmRNSProposed Placing
5th Aug 20215:28 pmRNSDirector/PDMR Shareholding
5th Aug 20215:27 pmRNSTotal Voting Rights
30th Jul 20217:00 amRNSHolding(s) in Company
29th Jul 20217:00 amRNSHolding(s) in Company
27th Jul 20217:01 amRNSChief Financial Officer Commencement Date
22nd Jul 20217:00 amRNSGrainger Reports Record Lease-up in Southampton
6th Jul 20211:31 pmRNSTotal Voting Rights
6th Jul 20211:31 pmRNSDirector/PDMR Shareholding
11th Jun 20217:00 amRNSAcquisition
8th Jun 202112:32 pmRNSHolding(s) in Company
7th Jun 20212:57 pmRNSDirector/PDMR Shareholding
20th May 202112:15 pmRNSTotal Voting Rights
13th May 20217:15 amRNSAcquisition
13th May 20217:00 amRNSHalf Year Financial Results
7th May 20219:41 amRNSDirector/PDMR Shareholding
28th Apr 202112:24 pmRNSDirector Declaration
22nd Apr 202111:46 amRNSNotice of Interim Results
7th Apr 20214:07 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.